Atlanticus (NASDAQ:ATLC – Get Free Report) had its price objective lowered by analysts at BTIG Research from $179.00 to $150.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a “buy” rating on the credit services provider’s stock. BTIG Research‘s target price would indicate a potential upside of 55.52% from the company’s previous close.
A number of other analysts have also commented on the company. Zacks Research lowered Atlanticus from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Citigroup restated an “outperform” rating on shares of Atlanticus in a report on Thursday, July 16th. Wall Street Zen raised Atlanticus from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 11th. Texas Capital upgraded Atlanticus from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Finally, Capital One Financial set a $144.00 price target on Atlanticus in a report on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $124.86.
Read Our Latest Report on ATLC
Atlanticus Trading Down 3.3%
NASDAQ:ATLC opened at $96.45 on Friday. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.26 and a quick ratio of 1.26. The firm has a 50-day moving average of $92.32 and a 200-day moving average of $80.93. The company has a market cap of $1.46 billion, a PE ratio of 12.54 and a beta of 1.80. Atlanticus has a one year low of $47.50 and a one year high of $114.34.
Atlanticus (NASDAQ:ATLC – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The credit services provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.01. Atlanticus had a net margin of 5.80% and a return on equity of 25.17%. The business had revenue of $775.85 million for the quarter, compared to analysts’ expectations of $775.08 million. As a group, equities research analysts expect that Atlanticus will post 9.73 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Atlanticus in the 2nd quarter worth about $43,535,000. Bank of New York Mellon Corp purchased a new stake in Atlanticus in the 2nd quarter valued at about $2,281,000. Susquehanna International Group LLP purchased a new stake in Atlanticus in the 2nd quarter valued at about $1,500,000. Philadelphia Financial Management of San Francisco LLC purchased a new stake in Atlanticus in the 2nd quarter valued at about $9,161,293. Finally, Denali Advisors LLC bought a new position in shares of Atlanticus during the 2nd quarter worth approximately $2,032,000. 14.15% of the stock is currently owned by hedge funds and other institutional investors.
Atlanticus Company Profile
Atlanticus Holdings Corporation is a financial technology and services company that provides credit and related financial products to consumers, primarily in the United States. Through its subsidiaries, the company focuses on serving consumers who may have limited access to traditional forms of credit.
Atlanticus operates businesses offering private-label and general-purpose credit products, including credit cards and installment loans. Its offerings are distributed through direct-to-consumer channels and partnerships with merchants, giving consumers access to financing for purchases and other personal needs.
The company also operates an auto finance business that provides vehicle-related lending solutions.
Further Reading
- Five stocks we like better than Atlanticus
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Atlanticus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlanticus and related companies with MarketBeat.com's FREE daily email newsletter.
